The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
NTRK fusion positive colorectal cancer as a unique subset of CRC with high tumor mutation burden and microsatellite instability.
No Relationships to Disclose
Qiuxiang Ou
Employment - Geneseeq Technology Inc.
Xue Wu
Employment - Geneseeq Technology Inc.
Leadership - Geneseeq Technology Inc.
Travel, Accommodations, Expenses - Geneseeq Technology Inc.
Misako Nagasaka
Consulting or Advisory Role - AstraZeneca; Caris Life Sciences; Daiichi Sankyo; EMD Serono; Novartis; Takeda
Speakers' Bureau - Blueprint Medicines
Research Funding - Tempus
Travel, Accommodations, Expenses - Anheart Therapeutics
Sai-Hong Ignatius Ou
Stock and Other Ownership Interests - Elevation Oncology; Turning Point Therapeutics
Honoraria - ARIAD/Takeda; AstraZeneca; Genentech/Roche; Pfizer; Roche Pharma AG
Consulting or Advisory Role - AstraZeneca; Jassen/JNJ; Pfizer; Roche/Genentech; Takeda
Speakers' Bureau - AstraZeneca; Genentech/Roche
Research Funding - ARIAD (Inst); AstraZeneca (Inst); AstraZeneca/MedImmune (Inst); Jassen/JNJ (Inst); Mirati Therapeutics (Inst); Pfizer (Inst); Revolution Medicines (Inst); Roche Pharma AG (Inst)
Yang Shao
Employment - Nanjing